NCT06900322

Impacts of a Physical Therapy Protocol on Motor Function in Children With Congenital Zika Syndrome

Completed NA Last updated 28 March 2025

What this trial tests

NA trial testing Experimental Group (stimuli and handling; physical therapy [PediaSuit]) in Congenital Zika Syndrome in 16 participants. Completed in 8 May 2018.

Timeline

15 January 2018

Primary endpoint
8 May 2018

8 May 2018

Quick facts

Lead sponsor	Gabriela Lopes Gama
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	16
Start date	15 January 2018
Primary completion	8 May 2018
Estimated completion	8 May 2018
Sites	1 location across Brazil

Drugs / interventions tested

• Experimental Group (stimuli and handling; physical therapy [PediaSuit])
• control group (conventional physical therapy)

Conditions studied

• Congenital Zika Syndrome — all drugs for Congenital Zika Syndrome →

Sponsor

Gabriela Lopes Gama

Who can join

Eligibility, any sex, with Congenital Zika Syndrome. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study aims to evaluate the effects of a specialized physiotherapy protocol aimed at the motor function of children with Congenital Zika Virus Syndrome. First, participants' anthropometric parameters (weight and length) and motor functions were assessed. After that participant were splited in two groups: Experimental group that uunderwent a one-hour daily protocol (5 times a week) of stimuli and handling based on the neuroevolutionary concept, and motor physical therapy with therapeutic garments (PediaSuit). On the other hand, the control group (CG) kept the therapeutic routine (conventional physical therapy).

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.